Evidence Brief: Psychedelic Medications for Mental Health and Substance Use Disorders

Washington (DC): Department of Veterans Affairs (US); 2022 Oct.


The ESP Coordinating Center (ESP CC) is responding to a request from the VA Office of Research and Development (ORD) and VHA Office of Mental Health and Suicide Prevention (OMHSP) for an Evidence Brief on the use of psychedelic substances for treating mental health and substance use disorders. Findings from this Evidence Brief will be used to inform VA research activities and clinical care in the areas of mental health and substance use disorder treatment.

Publication types

  • Review